Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

Episode 3 • May 05, 2026 • 00:27:48
Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?
LifeSci Talks
Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

May 05 2026 | 00:27:48

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, to discuss whether the field of clinical outcome assessment has started sacrificing “good for perfect.” Together, they explore the role of regulatory guidance and clinical development timelines, specifically the role of measurement science in already tight development timelines, when to modify a legacy instrument versus build something new, and why getting measurement scientists involved early is the key to a successful COA strategy.

Other Episodes

Episode 18

February 25, 2025 • 00:23:33
Episode Cover

Data Without Interpretation is Meaningless: Unlocking Inherent Value Within the Numbers

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Elizabeth (Nicki) Bush, Executive Director and...

Listen

Episode 15

November 10, 2026 • 00:22:16
Episode Cover

Clinical Trial Site Burden: Why One Study Can Mean Up to 15 Systems

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of...

Listen

Episode 9

January 30, 2024 • 00:26:26
Episode Cover

Licensing Considerations and eCOA Vendor Collaborations

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA &...

Listen